Literature DB >> 17852023

A method comparison in monitoring disease progression of G93A mouse model of ALS.

Chang Zhou1, Cui-Ping Zhao, Chen Zhang, Guo-Yong Wu, Fu Xiong, Cheng Zhang.   

Abstract

Our aim was to find an optimal method for monitoring disease progression and assessing the effectiveness of new agents in SOD1 mice. We compared six testing methods including clinical grading, weighing, hanging wire test, rotarod test, motor neuron counting and motor unit number estimation (MUNE) in SOD1 mice and control animals. The six methods were all able to differentiate between control animals and SOD1 transgenic mice at some time points; of them motor neuron counting, weighing and MUNE could detect abnormalities in presymptomatic stage in SOD1 mice; The number of functional motor units precisely correlated with motor neuron counts (r = 0.894, p<0.01). We concluded that MUNE is the better testing measure for monitoring disease and evaluating pharmacological therapies in SOD1 mice, which not only can reflect a meaningful biological effect of the agents used, but also is a sensitive, accurate and practical method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852023     DOI: 10.1080/17482960701538759

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  9 in total

1.  Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells.

Authors:  Nizar Souayah; K M Coakley; R Chen; Norman Ende; Joseph J McArdle
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

2.  Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.

Authors:  Lien-Szu Wu; Wei-Cheng Cheng; C-K James Shen
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis.

Authors:  Francisco Javier Miana-Mena; Cristina González-Mingot; Pilar Larrodé; María Jesús Muñoz; Sara Oliván; Lorena Fuentes-Broto; Enrique Martínez-Ballarín; Russel J Reiter; Rosario Osta; Joaquín José García
Journal:  J Neurol       Date:  2010-11-25       Impact factor: 4.849

4.  Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS.

Authors:  Ji-Yoen Kim; Ava Jang; Rohit Reddy; Wan Hee Yoon; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

5.  Region-specific changes in the immunoreactivity of Atg9A in the central nervous system of SOD1(G93A) transgenic mice.

Authors:  Jae Chul Lee; Soo Young Choe; Choong Ik Cha
Journal:  Anat Cell Biol       Date:  2014-06-20

6.  Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles.

Authors:  W David Arnold; Kajri A Sheth; Christopher G Wier; John T Kissel; Arthur H Burghes; Stephen J Kolb
Journal:  J Vis Exp       Date:  2015-09-25       Impact factor: 1.355

7.  Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.

Authors:  Elizabeth B Moloney; Barbara Hobo; Fred De Winter; Joost Verhaagen
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

8.  Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  John D Lee; Nur A Kamaruzaman; Jenny N T Fung; Stephen M Taylor; Bradley J Turner; Julie D Atkin; Trent M Woodruff; Peter G Noakes
Journal:  J Neuroinflammation       Date:  2013-09-26       Impact factor: 8.322

9.  Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mice.

Authors:  Christopher G Wier; Alexander E Crum; Anthony B Reynolds; Chitra C Iyer; Deepti Chugh; Marilly S Palettas; Patrick L Heilman; David M Kline; W David Arnold; Stephen J Kolb
Journal:  Muscle Nerve       Date:  2018-12-21       Impact factor: 3.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.